Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.
Nat Immunol. 2010 Jun;11(6):495-502. doi: 10.1038/ni.1878. Epub 2010 May 16.
Chemokines and other chemoattractants direct leukocyte migration and are essential for the development and delivery of immune and inflammatory responses. To probe the molecular mechanisms that underlie chemoattractant-guided migration, we did an RNA-mediated interference screen that identified several members of the synaptotagmin family of calcium-sensing vesicle-fusion proteins as mediators of cell migration: SYT7 and SYTL5 were positive regulators of chemotaxis, whereas SYT2 was a negative regulator of chemotaxis. SYT7-deficient leukocytes showed less migration in vitro and in a gout model in vivo. Chemoattractant-induced calcium-dependent lysosomal fusion was impaired in SYT7-deficient neutrophils. In a chemokine gradient, SYT7-deficient lymphocytes accumulated lysosomes in their uropods and had impaired uropod release. Our data identify a molecular pathway required for chemotaxis that links chemoattractant-induced calcium flux to exocytosis and uropod release.
趋化因子和其他趋化物质引导白细胞迁移,对于免疫和炎症反应的发展和传递至关重要。为了探究趋化因子引导迁移的分子机制,我们进行了 RNA 介导的干扰筛选,发现突触结合蛋白家族中的几个钙感应囊泡融合蛋白成员是细胞迁移的介质:SYT7 和 SYTL5 是趋化作用的正调节剂,而 SYT2 是趋化作用的负调节剂。SYT7 缺陷型白细胞在体外和体内痛风模型中的迁移能力降低。SYT7 缺陷型中性粒细胞中的趋化因子诱导的钙依赖性溶酶体融合受损。在趋化因子梯度中,SYT7 缺陷型淋巴细胞在其尾附器中积累溶酶体,并使尾附器释放受损。我们的数据确定了一个趋化作用所必需的分子途径,该途径将趋化因子诱导的钙流与胞吐作用和尾附器释放联系起来。